Celldex Therapeutics, Inc. Stock Nasdaq
Equities
US15117B1035
Biotechnology & Medical Research
Financials (USD)
Sales 2024 * | 2.83M | Sales 2025 * | 2.66M | Capitalization | 2.78B |
---|---|---|---|---|---|
Net income 2024 * | -164M | Net income 2025 * | -201M | EV / Sales 2024 * | 984 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1,047 x |
P/E ratio 2024 * |
-15.9
x | P/E ratio 2025 * |
-13.8
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.66% |
Latest transcript on Celldex Therapeutics, Inc.
Managers | Title | Age | Since |
---|---|---|---|
Tibor Keler
FOU | Founder | 65 | 82-12-31 |
Anthony Marucci
FOU | Founder | 62 | 82-12-31 |
Sam Martin
DFI | Director of Finance/CFO | 53 | 09-03-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Herbert Conrad
BRD | Director/Board Member | 91 | 08-02-29 |
Cheryl L. Cohen
BRD | Director/Board Member | 58 | 22-06-15 |
Harry H. Penner
BRD | Director/Board Member | 78 | 96-12-31 |
1st Jan change | Capi. | |
---|---|---|
+21.74% | 46.81B | |
-0.97% | 41.37B | |
+47.07% | 41.29B | |
-3.52% | 28.87B | |
+11.12% | 26.06B | |
-19.37% | 19.13B | |
+31.18% | 12.39B | |
-0.04% | 12.08B | |
+0.39% | 11.96B |